Register
Register
Register

University of Gabes

University

Gabes, Tunisia

About

The University of Gabes -UnivGb- covers the South-East district of Tunisia and four territorial governorates namely GABES, MEDENINE, KEBILI and TATAOUINE, rich in opportunities, both in terms of training and research. The UnivGb is now one of the eight Tunisian public universities that have been ranked in the advanced ranks of the new world ranking of universities, drawn up by the "Times Higher Education-THE" organization specializing in the ranking of universities in the world. Located in the South-East of Tunisia, Univgb covers four (4) governorates: Gabes, Medenine, Kebili and Tataouine. The regional economic environment is characterized by: • Varied agriculture (oasis, irrigation, fishing, ...), • Diversified industries (chemical industries, manufacturing, useful materials, agribusiness, ...), • Developed tourism sector (leisure, cultural and wellness), • Services sector. Gabes University includes many Higher Education Institutes (IES) receiving more than 15000 students. UnivGb offers aroun sixty bachelor's degrees in basic sciences, economics and management, humanities and legal sciences, arts and crafts, IT and multimedia. More than sixty master's degrees and 10 doctoral diplomas are also awarded. The academic staff of the University of Gabes belonging to numerous research laboratories (14) is active in cutting-edge scientific research fields dealing with pressing issues impacting the national and international communities. These scientific activities have led to 5000 SCOPUS publications and 50 bilateral collaboration agreements until 2022. Scientific staff of Gabes has the experience of participating, managing and cooperating in many European projects (H2020, Horizon Europe, Erasmus+…). We are open for cooperation. Looking forward to hearing from you.

Cluster 1: Health

HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate changeHORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potentialHORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from FlavivirusesHORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga virusesHORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobialsHORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medicationsHORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

Representatives

Associate professor

University of Gabes